EP0832103A1 - Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavour - Google Patents
Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavourInfo
- Publication number
- EP0832103A1 EP0832103A1 EP96917366A EP96917366A EP0832103A1 EP 0832103 A1 EP0832103 A1 EP 0832103A1 EP 96917366 A EP96917366 A EP 96917366A EP 96917366 A EP96917366 A EP 96917366A EP 0832103 A1 EP0832103 A1 EP 0832103A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- peptide
- cocoa
- peptides
- flavour
- cocoa flavour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 92
- 244000299461 Theobroma cacao Species 0.000 title claims abstract description 85
- 235000009470 Theobroma cacao Nutrition 0.000 title claims abstract description 76
- 239000000796 flavoring agent Substances 0.000 title claims abstract description 70
- 235000019634 flavors Nutrition 0.000 title claims abstract description 69
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 42
- 239000002243 precursor Substances 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 21
- 230000008569 process Effects 0.000 title claims description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 40
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 239000013598 vector Substances 0.000 claims abstract description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 11
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000013604 expression vector Substances 0.000 claims abstract description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 3
- 229940127557 pharmaceutical product Drugs 0.000 claims abstract description 3
- 239000002537 cosmetic Substances 0.000 claims abstract 2
- 235000001014 amino acid Nutrition 0.000 claims description 33
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 29
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 108020004414 DNA Proteins 0.000 claims description 20
- 235000018102 proteins Nutrition 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 10
- 108020004705 Codon Proteins 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 4
- 235000019219 chocolate Nutrition 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 208000035404 Autolysis Diseases 0.000 claims description 2
- 206010057248 Cell death Diseases 0.000 claims description 2
- 101000985493 Mus musculus Hermansky-Pudlak syndrome 3 protein homolog Proteins 0.000 claims description 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 235000014594 pastries Nutrition 0.000 claims description 2
- 230000028043 self proteolysis Effects 0.000 claims description 2
- 238000012799 strong cation exchange Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000002311 subsequent effect Effects 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 108020001507 fusion proteins Proteins 0.000 description 8
- 102000037865 fusion proteins Human genes 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 235000011846 forastero Nutrition 0.000 description 6
- 244000237494 forastero Species 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 108010074860 Factor Xa Proteins 0.000 description 5
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 5
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 235000001046 cacaotero Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000005720 Glutathione transferase Human genes 0.000 description 4
- 108010070675 Glutathione transferase Proteins 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000031787 nutrient reservoir activity Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 4
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940077731 carbohydrate nutrients Drugs 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- SFJUYBCDQBAYAJ-YDHLFZDLSA-N Asp-Val-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SFJUYBCDQBAYAJ-YDHLFZDLSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000030523 Catechol oxidase Human genes 0.000 description 2
- 108010031396 Catechol oxidase Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 239000012505 Superdex™ Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960000182 blood factors Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 235000008729 phenylalanine Nutrition 0.000 description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 1
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 1
- CPMKYMGGYUFOHS-FSPLSTOPSA-N Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O CPMKYMGGYUFOHS-FSPLSTOPSA-N 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- RWSXRVCMGQZWBV-UHFFFAOYSA-N L-Glutathione (reduced) Chemical compound OC(=O)C(N)CCC(=O)NC(CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010016634 Seed Storage Proteins Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010034546 Serratia marcescens nuclease Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 101710196023 Vicilin Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940043379 ammonium hydroxide Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008370 chocolate flavor Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000000322 laser mass spectrometry Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000007833 oxidative deamination reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 238000013492 plasmid preparation Methods 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/56—Liquid products; Solid products in the form of powders, flakes or granules for making liquid products, e.g. for making chocolate milk, drinks and the products for their preparation, pastes for spreading or milk crumb
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/21—Synthetic spices, flavouring agents or condiments containing amino acids
- A23L27/215—Synthetic spices, flavouring agents or condiments containing amino acids heated in the presence of reducing sugars, e.g. Maillard's non-enzymatic browning
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/10—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing amino-acids, proteins, e.g. gelatine, peptides, polypeptides
Definitions
- Cocoa flavour precursor peptides DNA encoding them, processes for producing the peptides, and their use for generating cocoa flavour
- This invention concerns peptides which are cocoa flavour precursors, DNA encoding these peptides, vectors contain ⁇ ing the DNA, host cells transformed therewith, and proc ⁇ esses for producing the peptides as well as their use for generating cocoa flavour.
- the peptides are isolated and characterized from West African cocoa beans isolated from the cocoa tree (Theobroma cacao) .
- Cocoa beans are seeds in cocoa pods which, after harvest ⁇ ing, are freed from the pods and subjected to a fermenta ⁇ tion process at or near the cultivation site, following which the greater part is exported for industrial proc- essing. Fermented cocoa beans are roasted, giving rise to the characteristic chocolate or cocoa flavour. The subse ⁇ quent grinding produces cocoa mass which is included as a main component in the chocolate production. Frequently, part of the cocoa mass is pressed, resulting in cocoa butter and cocoa powder, respectively.
- the fermentation process generates heat, ethanol and in particular acetic acid, and the microorganisms as such participate only indirectly in the process.
- the heat ac- tivates e.g. protein, oligosaccharide and polysaccharide cleaving endogenous enzymes, which are again inactivated in the last part of the fermentation process by rela ⁇ tively large amounts of acetic acid.
- Acetic acid diffuses into the fermented beans and, in addition to direct in- fluence on the degradation pattern and the rate, also ex ⁇ erts an indirect influence. The latter effect consists in changed location of both storage protein and in lipid in the beans. The result of the fermentation is thus i.a.
- peptides serve as flavour precursors .
- Cocoa and chocolate may be considered to belong to the range of food products whose flavour cannot be character ⁇ ized by a single or a few flavour components. Other exam ⁇ ples are boiled, roasted and grilled meat, baked bread and roasted coffee. The base flavour appears in all these food products as the overall impression of a balanced composition of many components.
- Cocoa flavour mainly consists of volatile components, but the sensory experience is a combination of taste and smell sensation. Mainly two groups of chemical compounds contributing to the flavour sensation are formed during roasting. These are aldehydes which are formed by oxida- tive deamination of amino acids, and pyrazines formed as Maillard reaction products.
- the patent represents one of the earliest lit ⁇ erature references for cocoa flavour substitutes from other raw materials, and is drafted in very broad terms.
- DDR Patent No. 205 815 published on January 11, 1984, which preferably concerns enzymatically produced protein hydrolysates of gelatine and wheat gluten.
- coli TGI (Amersham) was transformed with the vector, and the fusion protein was expressed (Sikorski, R.S. & Hieter, P. (1989) Genetics 122. 19-27).
- the fusion protein was isolated by means of a glutathione "Agarose”® affinity column. Fusion protein so isolated and containing blood factor Xa cleavage site was cleaved with factor Xa and applied to the affinity column once more, whereby glutathione-S-transferase was retained on the column, and the peptide of interest was eluted.
- the eluate was gel-filtered on a "Superdex®75" column (Pharmacia) by means of Pharmacia FPLC equipment. The fraction containing the peptide was rechromatographed on reverse phase column, following which the identity of the peptide was confirmed by means of mass spectrometry and amino acid sequence determination by Edman degrada ⁇ tion.
- the invention provides a cocoa flavour pre- cursor peptide selected from an isolated peptide with the amino acid sequence:
- the peptide of the invention is selected from fragments of the peptide with the above-mentioned sequence containing 2-9 amino acid residues calculated from the alanine residue No. 2, and it is preferably a nonapeptide with the amino acid sequence:
- the invention also comprises a DNA isolate comprising a DNA sequence encoding a peptide as stated above, which isolate, however, does not include the coding sequences of the 67 kD, 47 kD and 31 kD cocoa proteins.
- the DNA isolate of the invention comprises in particular the DNA sequence: 5'-AAR-GCN-CCN-TM-TC _ CCN _ GGN _ GAy _ GTN _ ⁇ _ GTN _3, or parts thereof of at least two codons in reading frame from the 5 '-terminus, and preferably the DNA sequence:
- a particularly useful DNA isolate of the invention which comprises the coding sequences of a blood coagulation factor Xa cleavage site and of the above-mentioned non- apeptide as well as various restriction sites, is useful for ligation in vectors which contain a gene encoding a larger protein, so that these express a fusion protein which is easier to purify, and from which the nonapeptide can easily be released by factor Xa.
- This DNA isolate has the DNA sequence:
- the invention moreover comprises vectors which contain the sequence of one of the above-mentioned DNA isolates, and in particular expression vectors which contain one or more copies of such a sequence operably linked to con ⁇ trol sequences which are recognized by a host cell trans ⁇ formed with the vector.
- recombinant host cells transformed with these vec ⁇ tors are comprised by the invention.
- Such host cells may be prokaryotes, e.g. Escherichia coli, or eukaryotes, e.g. yeast, mycelial fungi or cell lines of multi-cell organisms.
- Yeast which is a well-known microorganism widely used in the food industry, must be considered par ⁇ ticularly useful for producing cocoa flavour precursor peptides of the invention.
- the invention moreover comprises various processes for producing the peptides of the invention.
- the one best suited for industrial production of the peptides viz. by cultivation of a culture of a recombinant host cell, as stated above, and isolation of the resulting peptide from the cultivation mixture.
- the peptides of the invention may also be pro ⁇ quizzed by chemical synthesis from the individual amino ac ⁇ ids .
- the use of the peptides of the invention for producing cocoa flavour is also comprised by the invention.
- the invention comprises cocoa flavour produced by mixing of one or more peptides of the invention with predominantly reducing saccharides and amino acids and subsequent heat treatment of the mixture for 1-60 min at 100-200 °C, preferably for 5-15 min at 110-150 °C.
- the quantitative proportion between peptide(s), saccharides and amino acids is usually peptide(s) 30-90% by weight saccharides 10-40% by weight amino acids 0-30% by weight and preferably peptide(s) 50-80% by weight saccharides 15-35% by weight amino acids 5-15% by weight based on the total amount of these ingredients .
- the sac ⁇ charides in the mixture may practically consist of fruc ⁇ tose or glucose or mixtures thereof, preferably a mixture of fructose and glucose in a weight ratio from 3:1 to 1:3.
- the invention additionally comprises food products, cos ⁇ metic products and pharmaceutical products which have added thereto or contain a cocoa flavour, as stated above.
- the food products may be choco ⁇ late, confectionery, pastry or soft drinks.
- a particular embodiment of such products has been achieved in that during production they have been mixed with one or more peptides of the invention and, if necessary, predomi ⁇ nantly reducing saccharides and amino acids and then sub- jected to a heat treatment for 1-60 min at 100-200 °C, preferably for 5-15 min at 110-150 °C.
- Figure 1 shows a typical reverse phase chromatogram of an extract of defatted and autolyzed cocoa beans with 70% aqueous methanol .
- the nonapeptide Ala-Pro-Leu-Ser-Pro- Gly-Asp-Val-Phe having a particularly high cocoa flavour potential is isolated from the peak of the chromatogram which is marked by an arrow.
- Figure 2 shows a reverse phase chromatogram of said nona ⁇ peptide produced by a chemical synthesis.
- Figure 3 shows a reverse phase chromatogram of a peptide material isolated from an E. coli strain which has been transformed with a plasmid containing the code of said nonapeptide sequence. The nonapeptide is detected in the peak of the chromatogram which is marked by an arrow.
- MOBILE PHASE Acetonitrile gradient, 0-20% acetonitrile of 30 min followed by 20-100% acetonitrile of 10 min in 0.1% trifluoroacetic acid (TFA).
- TFA trifluoroacetic acid
- Ripe fresh cocoa pods from the Gold Coast, Ivory Coast were used for processing as described in this example. What was involved was a hybrid, widely distributed in the region, between two traditional cocoa tree types, Criollo and Amelonado, representing the most important African Forastero type.
- cocoa pods were divided into two halves by a sterile scalpel . The pulp was removed, and the beans were frozen in liquid nitrogen before drying in a freeze drier.
- the acetone residue was then washed with cold 0.05 M cit ⁇ rate buffer admixed with 0.15% thioglycolic acid and 10 mM EDTA at pH 4.0. The washing procedure was repeated with a large excess of buffer.
- the acid washed acetone residue thus produced and containing the greater part of the proteins and protein-related compounds (including en- dogenic enzymes) occurring in the beans was incubated with stirring at 50 °C in 0.2 M citrate buffer admixed with 0.5% thiogycolic acid at pH 4.0.
- PVPP polyvinyl polypyrrolidone
- Peptides and amino acids in the extract were then bound to washed and equilibrated strong cation exchanger ( "Dowex® 50W” ) , about 2.5 ml of wet ion ex- changer per gram of defatted bean. Then washing was per ⁇ formed in sequence with 20 and 80% 2-propanol followed by water to remove residual alcohol.
- the peptide fraction was liberated by basic elution (pH 10.7-11.0), and after the elution the pH value was lowered as quickly as possi- ble to about 7 by addition of HC1.
- the fraction was de ⁇ salted by means of cation exchanger and analyzed by re ⁇ verse phase chromatography (RPC).
- RPC re ⁇ verse phase chromatography
- bound peptides were eluted with ammoniumhydroxide (pH 12), which was subsequently removed as well as possible either by placement in an incubator under vacuum at 40 °C overnight or by freeze-drying.
- the peptide fraction obtained by 24 hour autoproteolysis and isolation as described above was analyzed by means of RPC. Use was made of PEP-RPC, HR 16/10 (Pharmacia) as a stationary phase and acetonitrile gradient (0-20% aceto ⁇ nitrile of 30 minutes and 20-100% of 10 minutes) in 0.1% TFA (trifluoroacetic acid) as a mobile phase with a flow rate of 7 ml/min, and UV detection (214 and 280 nm) .
- the FPLC system of Pharmacia was used, and a typical chroma ⁇ togram of the said autolysate appears from figure 1.
- the eluate was divided into three fractions, corre ⁇ sponding to hydrophilic and hydrophobic fractions and an intermediate fraction, respectively. It was found in roasting tests and subsequent sensory evaluation that the flavour potential was clearly best in the hydrophobic fraction and poorest in the hydrophilic fraction.
- thin layer roasting was used, as described by Mohr (Mohr, W. (1970) Fette, Seifen, Anstrichstoff 8 . , 695-704) comprising heat treatment at 130 °C for 8 min ⁇ utes.
- the peptide/protein fraction to be tested was roasted together with fructose, glucose and amino acid mixture in a weight ratio of 10:3:1:2. Samples of 20 mg were roasted (in some cases smaller amounts had to be roasted) , and to ensure good contact the samples were wetted and dried in vacuum at 40 °C before roasting.
- the amino acid mixture consisted of (% by weight) Alanine 10
- Fraction 38 was held to have a great flavour potential and was found to contain the above-mentioned nonapetide.
- the two strands were purified by polyacrylamide gel elec- trophoresis (PAGE) on 6% acrylamide gels containing urea (Sambrook, J. , Fritsch, E.F., and Maniatis, T. , (1989) In: Molecular Cloning - A Laboratory Manual ' . 11.23-11.28. 2nd ed., Cold Spring Harbor Lab. Press). Purified oli ⁇ gonucleotide strands were annealed to form the following double strand:
- the first five nucleotides consti ⁇ tute the greater part of the Bglll restriction site, which is AGATCT.
- the subsequent T is inserted to provide a correct reading frame.
- the two subsequent triplets, GGA and TCC, encode Gly and Ser, respectively, and constitute a BamHI restriction site which is inserted as a marker with a view to optional later PCR reaction.
- the triplets No. 4 and No. 3 from the 3 '-end of this synthetic oli- gonucleotide, which encode Asp-Val, are selected from the genetic code so as to form a BsaHI restriction site, GACGTC.
- the last triplet on this strand, TAG, is a stop codon.
- the TTAA sequence at the 5 '-end on the other strand constitutes four of the six nucleotides of the EcoRI restriction site.
- EcoRI and Bglll restriction was used for ligation into the pGEX-1 vector (Smith, D.B. & Johnson, K.S. (1988) Gene. 31-40), which contains a gene encoding glutathione- S-transferase localized so that expression in transformed bacteria causes synthesization of a fusion product be ⁇ tween this protein and the nonapeptide, which i.a. fa ⁇ cilitates purification and control of the expression product.
- the ligated plasmid was used for transformation of E. coli strain TGI supplied by Amersham (Hanahan, D. (1983), J. Mol. Biol. 166, 557-580).
- the above-mentioned BsaHI restriction site was introduced into the synthetic oli ⁇ gonucleotide to enable control of recombinant plasmid preparations by restriction mapping (Sambrook, J. et al. (1989), Molecular Cloning).
- the correct recombinant plas- mids were sequenced by the dideoxy method (Sanger, F., Nicklen, S., and Coulson, A.R., (1977) Proc. Natl . Acad. Sci. USA 24., 5463-5467; Sambrook, J. et al . (1989) Mo- lecular Cloning) .
- Transformed E. coli was cultivated in shaking bottles to AgQo of O- 7 " 1 - 0 at 28 °C, following which IPTG was added to a concentration of 0.1 mM for induction of the tac promoter. The cultures were cultivated for another 3-5 hours and then harvested.
- lyse buffer 50 mM Tris HCl, pH 8.0, 0.2 mg/ml of lysozyme, 1 mM EDTA
- the supernatant was applied to a glutathione "Agarose”® affinity column equilibrated in 50 mM Tris HCl, pH 8.0 at 8 °C.
- the column was washed with a buffer, and the fusion protein was eluted with a buffer admixed with 5 mM re- **d glutathione, dialyzed and analyzed by SDS poly- acrylamide gel electrophoresis on an 18% polyacrylamide gel.
- the protein concentration was determined by means of the Bradford method.
- the yield of fusion protein was de ⁇ termined to be about 12 mg per g of E. coli cells (wet weight) .
- Factor Xa cleavage (Nagai, K. & Th ⁇ gersen, H.C. (1984) Nature 309. 810-812) was performed as described by Knud- sen et al. (Knudsen, C.R., Clark, B.F.C., Degn, B., and Wiborg, 0., (1992) Biochem. Int. 2_, 352-362) with a few modifications. The weight ratio of protease to substrate was constantly kept at 1:200. After cleavage, affinity chromatography was again performed on the glutathione "Agarose”® affinity column, and pure nonapeptide was collected from the eluate.
- affinity chromatography was again performed on the glutathione "Agarose”® affinity column, and pure nonapeptide was collected from the eluate.
- the mass of the fusion protein and of the glutathione-S-transferase part of cleaved fusion protein was determined to 27 311 and 26 409, respectively, which, in view of the uncertainty of the method, corresponds to a difference that might be ascribed to the nonapeptide.
- FPLC analyses showed that a gel filtration ( "Superdex® 75") was necessary to remove various contaminants from the nonapeptide. Then the same elution profile was re- vealed under RPC (figure 3) as for nonapeptide isolated from cocoa beans and for nonapeptide produced by chemical synthesis. Plasma desorption mass spectrometry verified the identity of the microbially synthesized peptide.
- the sequence of the identified nonapeptide may be found as the amino acid residues Nos . 457 to 465 in the amino acid sequence of 67 kD cocoa seed storage protein precur ⁇ sor derived from the cDNA sequence ( International Patent Application No. WO 91/19801) and in the amino acid se ⁇ quence of cocoa seed vicilin derived from the gene se ⁇ quence (McHenry, L. _ Fritz, P.J. (1992), Plant Mol. Biol. 18., 1173-1176) .
- the nonapeptide isolated from cocoa beans is generated by endogenic enzyme activity and thus represents naturally produced peptides.
- the cleavage pattern reflects the en- dogenic enzyme activities under the given physical cir ⁇ cumstances, and, of course, it is conceivable that slightly changed conditions might give rise to new pep ⁇ tides that might have a unique flavour potential.
- the present study comprised studying the flavour potential of the nonapeptide extended by the next N-term- inal amino acid, lysine, and the next C-terminal amino acid, valine, occurring in the cocoa storage protein.
- a plurality of minor peptides was studied, whose identities are set forth below.
- the peptides were synthesized by chemical methods and then purified by HPLC prior to tests in roasting experiments. Nomenclature/peptide identity
- Ala- -2 Ala-Pro
- Ala- -6 Ala-Pro-Leu-Ser-Pro-Gly
- Ala- -7 Ala-Pro-Leu-Ser-Pro-Gly-Asp
- Ala- -8 Ala-Pro-Leu-Ser-Pro-Gly-Asp-Val
- Ala- -9 Ala-Pro-Leu-Ser-Pro-Gly-Asp-Val-Phe
- Pro- -7 Pro-Leu-Ser-Pro-Gly-Asp-Val
- Pro- -8 Pro-Leu-Ser-Pro-Gly-Asp-Val-Phe
- Lys- - 10 Lys-Ala-Pro-Leu-Ser-Pro-Gly-Asp-Val-Phe
- the nonapeptide was thus given a very positive evaluation when alanine was N-terminal, and thus confirmed the ob ⁇ servations from the cocoa bean isolate. Most of the minor peptides exhibited a not inconsiderable flavour poten ⁇ tial, and thus confirmed previous observations with frac ⁇ tionated cocoa bean isolate. In all experiments, the no ⁇ napeptide Ala-9 was evaluated as the clearly best one and being unique.
- endogenic enzymes which are responsible for the formation of the nonapeptide dur ⁇ ing incubation of cocoa beans, may have a great resemb ⁇ lance to trypsin and chymotrypsin and/or pepsin, respec ⁇ tively. This in order to be able to generate the correct terminal amino acids, alanine and phenylalanine.
- MOLECULE TYPE DNA (gen nic)
- HYPOTHETICAL NO
- ANTI-SENSE NO
- MOLECULE TYPE DNA (gencmic)
- HYPOTHETICAL NO
- ANTI-SENSE NO
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK061695A DK61695A (da) | 1995-06-01 | 1995-06-01 | Kakaoflavouraktive peptider, DNA som koder for dem, fremgangsmåder til fremstilling af peptiderne og deres anvendelse til frembringelse af kakaoflavour |
| DK61695 | 1995-06-01 | ||
| PCT/DK1996/000230 WO1996038472A1 (en) | 1995-06-01 | 1996-05-31 | Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavour |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0832103A1 true EP0832103A1 (en) | 1998-04-01 |
Family
ID=8095591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP96917366A Withdrawn EP0832103A1 (en) | 1995-06-01 | 1996-05-31 | Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavour |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0832103A1 (da) |
| AU (1) | AU5997096A (da) |
| DK (1) | DK61695A (da) |
| WO (1) | WO1996038472A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1235919B1 (en) * | 1999-11-18 | 2004-06-30 | Societe Des Produits Nestle S.A. | Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| EP1253200A1 (en) * | 2001-04-25 | 2002-10-30 | Société des Produits Nestlé S.A. | Cocoa polypeptides and their use in the production of cocoa and chocolate flavour |
| EP1298210A1 (en) * | 2001-10-01 | 2003-04-02 | Societe Des Produits Nestle S.A. | Cocoa flavour precursor peptides |
| EP1297753B1 (en) | 2001-10-01 | 2009-08-26 | Societe Des Produits Nestle S.A. | Flavour-active peptides |
| FR2883873B1 (fr) | 2005-03-31 | 2009-07-10 | Pharmamens Sarl | Inhibiteurs d'age |
| WO2011076954A1 (es) * | 2009-12-23 | 2011-06-30 | Biopolis S.L. | Obtencion de productos bioactivos procedentes del cacao con actividad inhibidora de la enzima pep y actividad antioxidante y/o antineurodegenerativa |
| CA2896246C (en) | 2013-01-22 | 2021-07-06 | Mars, Incorporated | Flavor composition and edible compositions containing same |
| WO2015177006A1 (en) * | 2014-05-19 | 2015-11-26 | Nestec S.A. | Mechanical generation of flavour compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9013016D0 (en) * | 1990-06-11 | 1990-08-01 | Mars Uk Ltd | Compounds |
-
1995
- 1995-06-01 DK DK061695A patent/DK61695A/da not_active Application Discontinuation
-
1996
- 1996-05-31 AU AU59970/96A patent/AU5997096A/en not_active Abandoned
- 1996-05-31 EP EP96917366A patent/EP0832103A1/en not_active Withdrawn
- 1996-05-31 WO PCT/DK1996/000230 patent/WO1996038472A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9638472A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5997096A (en) | 1996-12-18 |
| WO1996038472A1 (en) | 1996-12-05 |
| DK61695A (da) | 1996-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Voigt et al. | Cocoa-specific aroma precursors are generated by proteolytic digestion of the vicilin-like globulin of cocoa seeds | |
| KR101116923B1 (ko) | 조미료 | |
| NZ286835A (en) | Enzymatic treatment of cocoa nib or liquor | |
| WO1999002705A1 (en) | CLONING OF THE PROLYL-DIPEPTIDYL-PEPTIDASE FROM $i(ASPERGILLUS ORYZAE) | |
| CN100435653C (zh) | 香料活性肽 | |
| Voigt et al. | In vitro studies on the proteolytic formation of the characteristic aroma precursors of fermented cocoa seeds: The significance of endoprotease specificity | |
| EP0307071B1 (en) | Flavor and fragrance enhancing enzymes | |
| EP0832103A1 (en) | Cocoa flavour precursor peptides, dna encoding them, processes for producing the peptides, and their use for generating cocoa flavour | |
| Voigt et al. | The proteolytic formation of essential cocoaspecific aroma precursors depends on particular chemical structures of the vicilin-class globulin of the cocoa seeds lacking in the globular storage proteins of coconuts, hazelnuts and sunflower seeds | |
| US6927280B2 (en) | Cocoa albumin and its use in the production of cocoa and chocolate flavor | |
| JP2006160649A (ja) | 風味改善作用を有するペプチド、それを配合して得られる食品 | |
| US7176348B2 (en) | Cocoa polypeptides and their use in the production of cocoa and chocolate flavor | |
| JPH09295944A (ja) | 抗う蝕性素材、その製造方法および用途 | |
| KR100990667B1 (ko) | 높은 단맛을 가지는 신규한 브라제인 변이체 및 이의 용도 | |
| JPH10108686A (ja) | 呈味性ペプチドのクローニング、発現、および製造 | |
| JPH10316992A (ja) | 天然バニラ香料の製造方法 | |
| KR102896630B1 (ko) | 식물성 알부민 및 이의 제조 방법 | |
| US7311935B2 (en) | Carboxypeptidase of cocoa | |
| US6790650B2 (en) | Cacao endoproteinases and production of cocoa flavor from same | |
| JP3642910B2 (ja) | 処理穀物及びその製造方法 | |
| WO2024237271A1 (ja) | 風味の改善された大豆組成物の製造方法 | |
| JP5196469B2 (ja) | カルシウム結晶化阻害タンパク質 | |
| TW202541712A (zh) | 含酵母飲料及含酵母飲料之香味改善方法 | |
| TW202535260A (zh) | 含酵母飲料及含酵母飲料之呈味改善方法 | |
| JPH08173168A (ja) | アミノペプチダーゼ遺伝子、該遺伝子を含むプラスミドベクターおよび形質転換体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19971222 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL PAYMENT 971222;LT PAYMENT 971222;LV PAYMENT 971222;SI PAYMENT 971222 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19991202 |